Health and Fitness Health and Fitness
Wed, February 22, 2012
Tue, February 21, 2012
Mon, February 20, 2012
Sat, February 18, 2012
Fri, February 17, 2012
Thu, February 16, 2012
Wed, February 15, 2012
[ Wed, Feb 15th 2012 ] - Market Wire
Biogen Idec adquiere Stromedix
Tue, February 14, 2012
Mon, February 13, 2012
Sun, February 12, 2012
Fri, February 10, 2012
Thu, February 9, 2012

ERT to Report Fourth Quarter and Full Year 2011 Operating Results


//health-fitness.news-articles.net/content/2012/ .. uarter-and-full-year-2011-operating-results.html
Published in Health and Fitness on Wednesday, February 15th 2012 at 11:16 GMT by Market Wire   Print publication without navigation


ERT to Report Fourth Quarter and Full Year 2011 Operating Results -- PHILADELPHIA, Feb. 15, 2012 /PRNewswire/ --

ERT to Report Fourth Quarter and Full Year 2011 Operating Results

[ ]

PHILADELPHIA, Feb. 15, 2012 /PRNewswire/ -- ERT (NASDAQ: [ ERT ]) announced today that it will release its operating results for fourth quarter and full year 2011 Monday, February 27, after the market closes. After the release, the company will host a conference call at 5:00 PM ET that day.

For the conference call, interested participants should dial 1-800-860-2442 when calling within the United States or 1-412-858-4600 when calling internationally. There will be a playback available as well. To listen to the playback, please call 1-877-344-7529 when calling within the United States or 1-412-317-0088 when calling internationally.  Conference code for playback is 10010375.

This call is being webcast by MultiVu and can be accessed at ERT's website at [ www.ert.com ]. The webcast may also be accessed via the direct link at [ http://www.videonewswire.com/event.asp?id=85360 ]. The webcast can be accessed for up to one year on either site.

ERT ([ www.ert.com ]) is a global technology-driven provider of clinical services and customizable medical devices to biopharmaceutical and healthcare organizations.  It is the market leader for centralized cardiac safety and respiratory efficacy services in drug development and also collects, analyzes and distributes electronic Patient Reported Outcomes (ePRO) in multiple modalities across all phases of clinical research.

Statements included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve a number of risks and uncertainties, which could cause actual results to differ materially from those expressed or implied from such statements. These risks and uncertainties include, without limitation, the Company's ability to obtain new contracts, variability in size, scope, and duration of projects, integration of acquisitions, competitive factors, technological development, market demand, and other factors described in the Company's filings with the Securities and Exchange Commission.  The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.

­Media Contact:
Keith Schneck, CFO
Tel: 215-972-0420
[ kschneck@ert.com ]

 

SOURCE ERT

[ Back to top ]

RELATED LINKS
[ http://www.ert.com ]


Publication Contributing Sources